Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical responseCorey Smith, Rajiv Khanna, Katherine Matthews et al.|OncoImmunology|2017Cited by 72
Supplementary Table 1 from Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive ImmunotherapyCorey Smith, Rajiv Khanna, Janice Tsang et al.|Unknown|2023Cited by 0
Supplementary Table 1 from Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive ImmunotherapyCorey Smith, Rajiv Khanna, Janice Tsang et al.|Unknown|2023Cited by 0
Data from Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive ImmunotherapyCorey Smith, Rajiv Khanna, Janice Tsang et al.|Unknown|2023Cited by 0
Data from Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive ImmunotherapyCorey Smith, Rajiv Khanna, Janice Tsang et al.|Unknown|2023Cited by 0